DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells-Reference-Cited by-同舟云学术

DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells

Published:2017-11-24 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Sato Hiro,Niimi Atsuko,Yasuhara Takaaki^ORCID,Permata Tiara Bunga Mayang,Hagiwara Yoshihiko,Isono Mayu,Nuryadi Endang,Sekine Ryota,Oike Takahiro,Kakoti Sangeeta,Yoshimoto Yuya,Held Kathryn D.,Suzuki Yoshiyuki,Kono Koji,Miyagawa Kiyoshi,Nakano Takashi,Shibata Atsushi

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-01883-9.pdf

Reference60 articles.

1. Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887–3895 (1992).

2. Iwai, Y., Hamanishi, J., Chamoto, K. & Honjo, T. Cancer immunotherapies targeting the PD-1 signaling pathway. J. Biomed. Sci. 24, 26 (2017).

3. Freeman, G. J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).

4. Okazaki, T. & Honjo, T. PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19, 813–824 (2007).

5. Day, C. L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350–354 (2006).

Cited by 524 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable thermosensitive hydrogels loaded with irradiated tumor cell-derived microparticles and manganese activate anti-tumor immunity;Nano Today;2024-10

2. Cancer Stem Cell markers: Symphonic masters of chemoresistance and immune evasion;Life Sciences;2024-10

3. Genome-wide analysis reveals the MORC3-mediated repression of PD-L1 expression in head and neck cancer;Frontiers in Cell and Developmental Biology;2024-09-12

4. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;Clinical Lung Cancer;2024-09

5. Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer;Journal of Translational Medicine;2024-08-21